mutLBSgeneDB |
Gene summary for PHF21A |
![]() |
Basic gene Info. | Gene symbol | PHF21A |
Gene name | PHD finger protein 21A | |
Synonyms | BHC80 | |
Cytomap | UCSC genome browser: 11p11.2 | |
Type of gene | protein-coding | |
RefGenes | NM_001101802.1, NM_016621.3, | |
Description | BHC80aBRAF35-HDAC complex protein BHC80BRAF35/HDAC2 complex (80 kDa) | |
Modification date | 20141207 | |
dbXrefs | MIM : 608325 | |
HGNC : HGNC | ||
Protein | UniProt: Q96BD5 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PHF21A | |
BioGPS: 51317 | ||
Pathway | NCI Pathway Interaction Database: PHF21A | |
KEGG: PHF21A | ||
REACTOME: PHF21A | ||
Pathway Commons: PHF21A | ||
Context | iHOP: PHF21A | |
ligand binding site mutation search in PubMed: PHF21A | ||
UCL Cancer Institute: PHF21A | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 15325272 |
Top |
Ligand binding site mutations for PHF21A |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | C503 | C503Y | COAD | 1 | C494 | R495K | LUAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for PHF21A |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C503 | C503Y | -1.2365742 | C494 | R495K | -0.9693919 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for PHF21A |
![]() |
![]() |
Top |
Top |
Phenotype information for PHF21A |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for PHF21A |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 2puy | A | C494 | ZN | ZINC(2+) | 2puy | B | C494 | ZN | ZINC(2+) | 2puy | A | C503 | ZN | ZINC(2+) | 2puy | B | C503 |
Top |
Conservation information for LBS of PHF21A |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |